BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 16172101)

  • 1. Association of cytokine and DNA repair gene polymorphisms with hepatitis B-related hepatocellular carcinoma.
    Chen CC; Yang SY; Liu CJ; Lin CL; Liaw YF; Lin SM; Lee SD; Chen PJ; Chen CJ; Yu MW
    Int J Epidemiol; 2005 Dec; 34(6):1310-8. PubMed ID: 16172101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokine gene polymorphisms in Japanese patients with hepatitis B virus infection--association between TGF-beta1 polymorphisms and hepatocellular carcinoma.
    Migita K; Miyazoe S; Maeda Y; Daikoku M; Abiru S; Ueki T; Yano K; Nagaoka S; Matsumoto T; Nakao K; Hamasaki K; Yatsuhashi H; Ishibashi H; Eguchi K
    J Hepatol; 2005 Apr; 42(4):505-10. PubMed ID: 15763337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A p53 genetic polymorphism as a modulator of hepatocellular carcinoma risk in relation to chronic liver disease, familial tendency, and cigarette smoking in hepatitis B carriers.
    Yu MW; Yang SY; Chiu YH; Chiang YC; Liaw YF; Chen CJ
    Hepatology; 1999 Mar; 29(3):697-702. PubMed ID: 10051470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-1beta gene polymorphisms associated with hepatocellular carcinoma in hepatitis C virus infection.
    Wang Y; Kato N; Hoshida Y; Yoshida H; Taniguchi H; Goto T; Moriyama M; Otsuka M; Shiina S; Shiratori Y; Ito Y; Omata M
    Hepatology; 2003 Jan; 37(1):65-71. PubMed ID: 12500190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of HLA-DRB1*13 and TNF-alpha gene polymorphisms with clearance of chronic hepatitis B infection and risk of hepatocellular carcinoma in Thai population.
    Kummee P; Tangkijvanich P; Poovorawan Y; Hirankarn N
    J Viral Hepat; 2007 Dec; 14(12):841-8. PubMed ID: 18070287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocellular carcinoma and polymorphisms in carcinogen-metabolizing and DNA repair enzymes in a population with aflatoxin exposure and hepatitis B virus endemicity.
    Kirk GD; Turner PC; Gong Y; Lesi OA; Mendy M; Goedert JJ; Hall AJ; Whittle H; Hainaut P; Montesano R; Wild CP
    Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):373-9. PubMed ID: 15734960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction between interleukin-1beta -31T/C gene polymorphism and drinking and smoking habits on the risk of hepatocellular carcinoma among Japanese.
    Sakamoto T; Higaki Y; Hara M; Ichiba M; Horita M; Mizuta T; Eguchi Y; Yasutake T; Ozaki I; Yamamoto K; Onohara S; Kawazoe S; Shigematsu H; Koizumi S; Tanaka K
    Cancer Lett; 2008 Nov; 271(1):98-104. PubMed ID: 18603357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A p53 polymorphism modifies the risk of hepatocellular carcinoma among non-carriers but not carriers of chronic hepatitis B virus infection.
    Zhu ZZ; Cong WM; Liu SF; Xian ZH; Wu WQ; Wu MC; Gao B; Hou LF; Zhu GS
    Cancer Lett; 2005 Nov; 229(1):77-83. PubMed ID: 15979781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. UDP-glucuronosyltransferase 1A7 genetic polymorphisms are associated with hepatocellular carcinoma risk and onset age.
    Tseng CS; Tang KS; Lo HW; Ker CG; Teng HC; Huang CS
    Am J Gastroenterol; 2005 Aug; 100(8):1758-63. PubMed ID: 16086712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men.
    Yu MW; Yeh SH; Chen PJ; Liaw YF; Lin CL; Liu CJ; Shih WL; Kao JH; Chen DS; Chen CJ
    J Natl Cancer Inst; 2005 Feb; 97(4):265-72. PubMed ID: 15713961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen receptor alpha polymorphisms associated with susceptibility to hepatocellular carcinoma in hepatitis B virus carriers.
    Zhai Y; Zhou G; Deng G; Xie W; Dong X; Zhang X; Yu L; Yang H; Yuan X; Zhang H; Zhi L; Yao Z; Shen Y; Qiang B; He F
    Gastroenterology; 2006 Jun; 130(7):2001-9. PubMed ID: 16762623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphisms of interleukin-1beta in Japanese patients with hepatitis B virus infection.
    Migita K; Maeda Y; Abiru S; Nakamura M; Komori A; Miyazoe S; Nakao K; Yatsuhashi H; Eguchi K; Ishibashi H
    J Hepatol; 2007 Mar; 46(3):381-6. PubMed ID: 17126449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basal core promoter mutations of hepatitis B virus increase the risk of hepatocellular carcinoma in hepatitis B carriers.
    Kao JH; Chen PJ; Lai MY; Chen DS
    Gastroenterology; 2003 Feb; 124(2):327-34. PubMed ID: 12557138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined polymorphism analysis of glutathione S-transferase M1/G1 and interleukin-1B (IL-1B)/interleukin 1-receptor antagonist (IL-1RN) and gastric cancer risk in an Omani Arab Population.
    Al-Moundhri MS; Alkindy M; Al-Nabhani M; Al-Bahrani B; Burney IA; Al-Habsi H; Ganguly SS; Tanira M
    J Clin Gastroenterol; 2009 Feb; 43(2):152-6. PubMed ID: 18779738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of cytokine genotypes on the hepatitis B virus-hepatocellular carcinoma association.
    Nieters A; Yuan JM; Sun CL; Zhang ZQ; Stoehlmacher J; Govindarajan S; Yu MC
    Cancer; 2005 Feb; 103(4):740-8. PubMed ID: 15643599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High viral load and hepatitis B virus subgenotype ce are associated with increased risk of hepatocellular carcinoma.
    Chan HL; Tse CH; Mo F; Koh J; Wong VW; Wong GL; Lam Chan S; Yeo W; Sung JJ; Mok TS
    J Clin Oncol; 2008 Jan; 26(2):177-82. PubMed ID: 18182659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of XRCC1, XRCC3, and XPD genetic polymorphism with an increased risk of hepatocellular carcinoma because of the hepatitis B and C virus.
    Gulnaz A; Sayyed AH; Amin F; Khan Au; Aslam MA; Shaikh RS; Ali M
    Eur J Gastroenterol Hepatol; 2013 Feb; 25(2):166-79. PubMed ID: 23044807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genotypic and functional roles of IL-1B and IL-1RN on the risk of gastroesophageal reflux disease: the presence of IL-1B-511*T/IL-1RN*1 (T1) haplotype may protect against the disease.
    Chourasia D; Achyut BR; Tripathi S; Mittal B; Mittal RD; Ghoshal UC
    Am J Gastroenterol; 2009 Nov; 104(11):2704-13. PubMed ID: 19603010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Relationship of interleukin-1B and interleukin-1 receptor antagonist gene polymorphisms with chronic hepatitis B].
    Zhang PA; Li Y; Xu P
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Dec; 20(6):508-11. PubMed ID: 14669220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SPP1 polymorphisms associated with HBV clearance and HCC occurrence.
    Shin HD; Park BL; Cheong HS; Yoon JH; Kim YJ; Lee HS
    Int J Epidemiol; 2007 Oct; 36(5):1001-8. PubMed ID: 17496055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.